We are live on
!
Find out more
PP
PDT Partners Portfolio holdings
AUM
$1.69B
1-Year Est. Return
74.01%
This Fund
S&P 500
This Quarter
Est. Return
+40.55%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.47B
AUM Growth
+$207M
(+16%)
Cap. Flow
-$137M
Cap. Flow
% of AUM
-9.32%
Top 10 Holdings %
Top 10 Hldgs %
9.07%
Holding
898
New
262
Increased
152
Reduced
230
Closed
245
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bloom Energy
BE
|
+$9.29M |
| 2 |
ZEN
ZENDESK INC
ZEN
|
+$9.24M |
| 3 |
NetApp
NTAP
|
+$8.82M |
| 4 |
Bright Horizons
BFAM
|
+$8.68M |
| 5 |
Eli Lilly
LLY
|
+$8.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$31.8M |
| 2 |
Humana
HUM
|
+$24.8M |
| 3 |
EOG Resources
EOG
|
+$17.3M |
| 4 |
HF Sinclair
DINO
|
+$9.96M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$9.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.74% |
| 2 | Healthcare | 23.44% |
| 3 | Consumer Discretionary | 13.66% |
| 4 | Industrials | 10.93% |
| 5 | Financials | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Enbridge
ENB
$121B
| $256K | 0.02% |
+8,429
| New | +$259K |
|
552
McGrath RentCorp
MGRC
$2.92B
| $256K | 0.02% |
+4,738
| New | +$254K |
|
|
ODT
553
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $256K | 0.02% |
6,049
-6,351
| -51% | -$206K |
|
|
BFX
554
DELISTED
BowFlex Inc.
BFX
| $252K | 0.02% |
+27,204
| New | +$165K |
|
555
Essent Group
ESNT
$6.24B
| $250K | 0.02% |
+6,901
| New | +$212K |
|
556
Origin Bancorp
OBK
$1.69B
| $250K | 0.02% |
+11,376
| New | +$233K |
|
557
Wabash National
WNC
$539M
| $250K | 0.02% |
+23,571
| New | +$208K |
|
558
Hamilton Lane
HLNE
$3.91B
| $249K | 0.02% |
+3,693
| New | +$233K |
|
|
ROCC
559
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $249K | 0.02% |
+26,101
| New | +$202K |
|
|
RST
560
DELISTED
ROSETTA STONE INC
RST
| $248K | 0.02% |
14,700
+1,400
| +11% | +$23.5K |
|
561
eGain
EGAN
$191M
| $247K | 0.02% |
22,250
+4,250
| +24% | +$38.7K |
|
562
Energy Recovery
ERII
$435M
| $246K | 0.02% |
32,400
+14,000
| +76% | +$111K |
|
|
CHX
563
DELISTED
ChampionX
CHX
| $243K | 0.02% |
24,893
-45,361
| -65% | -$416K |
|
564
CRA International
CRAI
$1.17B
| $241K | 0.02% |
+6,100
| New | +$232K |
|
565
Heartland Express
HTLD
$1.05B
| $239K | 0.02% |
11,487
+881
| +8% | +$17.7K |
|
566
Cohen & Steers
CNS
$4.21B
| $238K | 0.02% |
+3,500
| New | +$211K |
|
567
Vitamin Cottage Natural Grocers
NGVC
$754M
| $238K | 0.02% |
16,000
+1,480
| +10% | +$18K |
|
568
First Merchants
FRME
$2.74B
| $237K | 0.02% |
8,586
+50
| +0.6% | +$1.34K |
|
569
CRISPR Therapeutics
CRSP
$4.65B
| $236K | 0.02% |
+3,215
| New | +$188K |
|
570
Lindsay Corp
LNN
$1.18B
| $236K | 0.02% |
2,563
| – | – |
|
|
FPRX
571
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $236K | 0.02% |
38,750
-30,350
| -44% | -$125K |
|
572
MSCI
MSCI
$42.1B
| $235K | 0.02% |
+704
| New | +$228K |
|
573
Gossamer Bio
GOSS
$94.4M
| $232K | 0.02% |
+17,831
| New | +$224K |
|
574
Vera Bradley
VRA
$106M
| $232K | 0.02% |
52,211
-615
| -1% | -$3.06K |
|
575
Pultegroup
PHM
$25.5B
| $230K | 0.02% |
+6,763
| New | +$203K |
|
Similar funds
ISS
GAM
BCM
FACM
TCBWMS
SGI
AAM
RSCM
PDT Partners's Q2 2020 Portfolio in Review
As of Q2 2020, PDT Partners held 898 positions worth $1.47B, up 16% from $1.26B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
PDT Partners withdrew a net $137M in Q2 2020, closing 245 positions and reducing 230 holdings. Its most notable exit was AbbVie, an estimated $31.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, PDT Partners opened a new position in ZENDESK INC worth $10.6M.
- PDT Partners's largest Q2 2020 buy was ZENDESK INC: 119,997 shares worth $10.6M.
- PDT Partners added most to Bloom Energy in Q2 2020, an estimated $9.29M increase.
- PDT Partners's biggest Q2 2020 reduction was EOG Resources, cutting an estimated $17.3M.
- PDT Partners fully exited AbbVie in Q2 2020, selling an estimated $31.8M.
- PDT Partners's ten largest holdings make up 9.1% of its $1.47B portfolio in Q2 2020.
- PDT Partners opened 262 new positions and closed 245 in Q2 2020.
- PDT Partners's portfolio value rose 16% quarter-over-quarter to $1.47B.
Based on PDT Partners's 13F filing for Q2 2020, filed 14 Aug 2020.